GENEOS THERAPEUTICS

Geneos Therapeutics, a Phase 2 biotherapeutics company, is developing DNA-based personalized therapeutic cancer vaccines (PTCVs) which may serve an important role as a new immunotherapeutic paradigm for cancer.

Also known as: Geneos Therapeutics, Inc.

Primary location: Philadelphia United States